| Code | CSB-RA025166MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody described in US9487586B2, specifically targeting TSPAN8 (tetraspanin-8). TSPAN8 is a member of the tetraspanin superfamily of cell surface glycoproteins that organize membrane microdomains and regulate cellular processes including adhesion, migration, and signal transduction. This protein plays a critical role in tumor progression and metastasis, particularly in pancreatic, colorectal, and hepatocellular carcinomas, where its overexpression correlates with poor prognosis and increased invasive potential. TSPAN8 facilitates cancer cell dissemination by modulating integrin function and promoting the formation of tumor-derived exosomes that prepare pre-metastatic niches.
The reference antibody patent covers therapeutic and diagnostic applications for TSPAN8-expressing cancers. This biosimilar provides researchers with a valuable tool for investigating TSPAN8-mediated oncogenic mechanisms, studying tetraspanin biology, evaluating tumor biomarkers, and exploring potential therapeutic interventions in TSPAN8-positive malignancies. The antibody supports diverse research applications in cancer biology, metastasis studies, and exosome research.
There are currently no reviews for this product.